These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 28445879)

  • 1. Cytokine and Chemokine Profiles in Patients with Neuromyelitis Optica Spectrum Disorder.
    Wang Y; Zhou Y; Sun X; Lu T; Wei L; Fang L; Chen C; Huang Q; Hu X; Lu Z; Peng L; Qiu W
    Neuroimmunomodulation; 2016; 23(5-6):352-358. PubMed ID: 28445879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokines and Tissue Damage Biomarkers in First-Onset Neuromyelitis Optica Spectrum Disorders: Significance of Interleukin-6.
    Wei Y; Chang H; Li X; Wang H; Du L; Zhou H; Xu W; Ma Y; Yin L; Zhang X
    Neuroimmunomodulation; 2018; 25(4):215-224. PubMed ID: 30544111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristic cerebrospinal fluid cytokine/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis.
    Matsushita T; Tateishi T; Isobe N; Yonekawa T; Yamasaki R; Matsuse D; Murai H; Kira J
    PLoS One; 2013; 8(4):e61835. PubMed ID: 23637915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications.
    Kaneko K; Sato DK; Nakashima I; Ogawa R; Akaishi T; Takai Y; Nishiyama S; Takahashi T; Misu T; Kuroda H; Tanaka S; Nomura K; Hashimoto Y; Callegaro D; Steinman L; Fujihara K; Aoki M
    J Neurol Neurosurg Psychiatry; 2018 Sep; 89(9):927-936. PubMed ID: 29875186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resolution of inflammation in neuromyelitis optica spectrum disorders.
    Wang X; Jiao W; Lin M; Lu C; Liu C; Wang Y; Ma D; Wang X; Yin P; Feng J; Zhu J; Zhu M
    Mult Scler Relat Disord; 2019 Jan; 27():34-41. PubMed ID: 30300851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of anti-aquaporin 4 antibody in a diagnostic cohort of patients being investigated for possible neuromyelitis optica spectrum disorder in Western Australia.
    Fabis-Pedrini MJ; Bundell C; Wee CK; Lucas M; McLean-Tooke A; Mastaglia FL; Carroll WM; Kermode AG
    J Neuroimmunol; 2018 Nov; 324():76-80. PubMed ID: 30248527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Features of Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders.
    Chen H; Liu SM; Zhang XX; Liu YO; Li SZ; Liu Z; Dong HQ
    Chin Med J (Engl); 2016 Sep; 129(17):2079-84. PubMed ID: 27569235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Th2 axis-related cytokines in patients with neuromyelitis optica spectrum disorders.
    Zhang Y; Yao XY; Gao MC; Ding J; Hong RH; Huang H; Zhuang L; Wang YG; Hao Y; Guan YT
    CNS Neurosci Ther; 2018 Jan; 24(1):64-69. PubMed ID: 29110391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid mitochondrial DNA in neuromyelitis optica spectrum disorder.
    Yamashita K; Kinoshita M; Miyamoto K; Namba A; Shimizu M; Koda T; Sugimoto T; Mori Y; Yoshioka Y; Nakatsuji Y; Kumanogoh A; Kusunoki S; Mochizuki H; Okuno T
    J Neuroinflammation; 2018 Apr; 15(1):125. PubMed ID: 29703264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased cerebrospinal fluid progranulin correlates with interleukin-6 in the acute phase of neuromyelitis optica spectrum disorder.
    Kimura A; Takemura M; Saito K; Serrero G; Yoshikura N; Hayashi Y; Inuzuka T
    J Neuroimmunol; 2017 Apr; 305():175-181. PubMed ID: 28100408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The levels of circulating cytokines and risk of neuromyelitis optica spectrum disorder: a Mendelian randomization study.
    Ma X; Wang Y; Chen X; Guo J
    Front Immunol; 2024; 15():1418309. PubMed ID: 39011048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-C1q autoantibodies in patients with neuromyelitis optica spectrum disorders.
    Yoshikura N; Kimura A; Hayashi Y; Inuzuka T
    J Neuroimmunol; 2017 Sep; 310():150-157. PubMed ID: 28756870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status.
    Yoshimura S; Isobe N; Matsushita T; Yonekawa T; Masaki K; Sato S; Kawano Y; Kira J;
    J Neurol Neurosurg Psychiatry; 2013 Jan; 84(1):29-34. PubMed ID: 23038741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea.
    Seok JM; Cho HJ; Ahn SW; Cho EB; Park MS; Joo IS; Shin HY; Kim SY; Kim BJ; Kim JK; Cho JY; Huh SY; Kwon O; Lee KH; Kim BJ; Min JH
    Mult Scler; 2017 Nov; 23(13):1748-1756. PubMed ID: 28058965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EBI2-expressing B cells in neuromyelitis optica spectrum disorder with AQP4-IgG: Association with acute attacks and serum cytokines.
    Baek SH; Kim B; Shin JY; Choi SJ; Ahn SH; Choi YS; Kim SM; Sung JJ
    J Neuroimmunol; 2021 Sep; 358():577637. PubMed ID: 34229205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma Homocysteine Level Is Associated with the Expanded Disability Status Scale in Neuromyelitis Optica Spectrum Disorder.
    Liang J; Liu J; Fan R; Chen Z; Chen X; Tong J; Chen Y; Peng F; Jiang Y
    Neuroimmunomodulation; 2019; 26(5):258-264. PubMed ID: 31655825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal Fluid Level of Soluble CD27 Is Associated with Disease Severity in Neuromyelitis Optica Spectrum Disorder.
    Liu B; Zhong X; Lu Z; Qiu W; Hu X; Wang H
    Neuroimmunomodulation; 2018; 25(4):185-192. PubMed ID: 30423585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the binding pattern of human aquaporin-4 autoantibodies in patients with neuromyelitis optica spectrum disorders.
    Tuller F; Holzer H; Schanda K; Aboulenein-Djamshidian F; Höftberger R; Khalil M; Seifert-Held T; Leutmezer F; Berger T; Reindl M
    J Neuroinflammation; 2016 Jul; 13(1):176. PubMed ID: 27371173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low levels of vitamin D and the relationship between vitamin D and Th2 axis-related cytokines in neuromyelitis optica spectrum disorders.
    Gao M; Yao X; Ding J; Hong R; Wu Y; Huang H; Zhuang L; Li Z; Wang Y; Zhang Y; Guan Y
    J Clin Neurosci; 2019 Mar; 61():22-27. PubMed ID: 30692037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated chemokines and cytokines for eosinophils in neuromyelitis optica spectrum disorders.
    Du L; Chang H; Xu W; Zhang X; Yin L
    Mult Scler Relat Disord; 2021 Jul; 52():102940. PubMed ID: 33930716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.